Identification of anti-Lea by platelet complement fixation

Area of Science:

• Immunology
• Transfusion Medicine
• Serology

Background:

• Platelet antigen detection is crucial for transfusion compatibility.
• The Lea antigen, typically found on red blood cells, has also been detected on platelets.
• Understanding anti-platelet antibodies is vital for managing transfusion reactions.

Purpose of the Study:

• To identify and characterize novel anti-platelet antibodies.
• To investigate the presence and behavior of anti-Lea antibodies in relation to platelets.
• To determine the clinical implications for platelet transfusion strategies.

Main Methods:

• Screening for anti-platelet antibodies using a platelet complement fixation test.
• Hemolysis assays on erythrocytes.
• Antibody absorption studies using red cells, platelets, and lymphocytes from donors with different Lewis phenotypes (Le(a+b-), Le(a-b+), Le(a-b-)).
• Dithiothreitol treatment to assess antibody class (IgM vs. IgG).

Main Results:

• Two anti-Lea sera were identified, detecting Lea antigen on platelets.
• These sera caused hemolysis of erythrocytes without enzyme treatment.
• Antibody activity was specifically absorbed by Le(a+b-) cells, confirming anti-Lea specificity.
• Dithiothreitol treatment eliminated antibody activity, indicating an IgM immunoglobulin class.
• Anti-Lea antibodies showed higher reactivity at 37°C compared to room temperature.

Conclusions:

• The identified antibodies are IgM class anti-Lea, reactive with both red cells and platelets.
• Transfusion of Lea-negative platelets is recommended for patients with this specific anti-Lea antibody.
• This finding has implications for preventing alloimmunization and transfusion reactions in susceptible individuals.